MHRA Leadership—none of them have any experience of approving medicinal products—holy moley!!!

Let's take a skip through their biographies...

The MHRA Leadership Team

It’s hard to believe that such a motley crew at MHRA is in charge of keeping patients safe from dangerous medicinal products. Let’s take a look at the six of them:

Dame June Raine DBE (Chief Executive):

“She was elected in 2012 as the first chair of the European Pharmacovigilance Risk Assessment Committee and is also co-Chair of the WHO Advisory Committee on Safety of Medicinal Products. Her special interests are in monitoring the outcomes of regulatory action, risk communication and patient involvement in the regulatory process.” Previous appointment:

“Director of Vigilance and Risk Management of Medicines, 1999 to 2019”

That means she has no experience of the approval process for medicinal products, nothing, zilch, zippo, nowt.

Hopefully, Raine’s second-in-command has a better handle on things: